News Focus
News Focus
Followers 9
Posts 3969
Boards Moderated 0
Alias Born 07/27/2023

Re: None

Monday, 01/19/2026 11:37:27 PM

Monday, January 19, 2026 11:37:27 PM

Post# of 867027
Google Artifical Intelligence Speaketh
Q - forecast for FNMA stock for 1/20/2026
A - For January 20, 2026, forecasts for FNMA (Fannie Mae) stock are mixed but lean cautious, with analysts giving a general "Hold" rating, expecting short-term weakness or sideways movement due to current negative technicals, yet pointing to potential upside towards $12-$13+ range if conservatorship issues resolve, though some models suggest overvaluation
. Stockinvest.us predicts weak short-term performance with a fair opening price around $8.88, while MarketBeat and Zacks show average analyst targets of $12.88-$13.25, reflecting significant upside potential, notes www.zacks.com/stock/research/FNMA/price-target-stock-forecast.
Analyst Sentiment & Targets (as of mid-Jan 2026):
Consensus Rating: Mostly "Hold," with some Sell signals.
Average Price Targets: Around $12.88 (MarketBeat) to $13.25 (Zacks) for the next 12 months, with highs up to $20.
Short-Term Outlook: Negative signals from moving averages suggest weak performance in the immediate days/weeks, notes StockInvest.us.
Key Factors & Views:
Technical Analysis: Indicates bearish trends with sell signals from moving averages (MACD).
Valuation Models: A Discounted Cash Flow (DCF) model suggests significant overvaluation compared to its intrinsic value, notes Simply Wall Street.
Conservatorship: Analyst views differ on whether resolution will unlock potential (Deutsche Bank's $20 target) or if the stock is already inflated.
In Summary: While analyst targets suggest upside for the year, short-term technicals and valuation models present a mixed picture for FNMA as of early 2026, pointing towards potential near-term weakness or stagnation, say MarketBeat and Zacks Investment Research.
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent FNMA News